FBLN1 and rheumatic heart disease: Our data showing a 46% higher mean value plasma fibulin-1 in RHD cases compared to controls, particularly when coupled with the pro-inflammatory signature constituted by other proteins, tends to support the notion of ongoing valve damage in late-stage RHD.